QUOTED. 12 March 2020. Andreas Papadopoulos.
LivaNova announced its vagus nerve stimulation system Symmetry has earned the CE mark to treat chronic or recurrent depression. See what Andreas Papadopoulos, clinical director at Somerset Partnership National Health Service Foundation Trust, said about the device here.
"With depression affecting so many people in the UK and so many patients suffering from symptoms despite traditional therapy, we were excited to develop a treatment pathway that can be replicated throughout the country, giving more patients with difficult-to-treat depression access to VNS therapy and Symmetry. Working with Ear, Nose and Throat (ENT) surgical services enabled us to achieve swift and expert implantation of Symmetry devices for both patients." – Andreas Papadopoulos, clinical director, Somerset Partnership National Health Service Foundation Trust
Click here for a free trial of Medtech Insight